+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Microbiome Market - Global Forecast 2025-2030- Product Image
Human Microbiome Market - Global Forecast 2025-2030- Product Image
Sale

Human Microbiome Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4857894
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The human microbiome market is evolving rapidly, shaped by advances in microbial science, strategic industry collaborations, and emerging clinical applications. Senior stakeholders are recalibrating business models to capture growth, maximize translational innovation, and remain competitive within the evolving healthcare landscape.

Market Snapshot: Human Microbiome Market Growth & Outlook

The human microbiome market grew from USD 1.96 billion in 2024 to USD 2.44 billion in 2025. It is expected to continue growing at a CAGR of 24.01%, reaching USD 7.13 billion by 2030. This expansion reflects strong demand for advanced sequencing, therapeutics, diagnostics, and personalized nutrition solutions. Across global health systems, the imperative to leverage microbiome science for targeted intervention is accelerating, opening up new strategic avenues for life sciences leaders and investors.

Scope & Segmentation of the Human Microbiome Market

This report provides a comprehensive analysis of the human microbiome industry, covering both mature offerings and emerging pipelines. It maps product categories, key applications, and all relevant geographies critical for industry planning. Segmentation highlights include:

  • Product Types: Fecal microbiota transplant via capsule or colonoscopy, microbiome sequencing services such as 16S rRNA sequencing, metatranscriptomics and shotgun metagenomics; postbiotics, prebiotics including fructooligosaccharides, galactooligosaccharides, inulin; probiotics like Bifidobacterium and Lactobacillus; synbiotics.
  • Indications: Coverage spans gastrointestinal and metabolic disorders, infections, oral health, respiratory and skin disorders.
  • Applications: Diagnostics including biomarker discovery, clinical diagnostics, companion diagnostics; supplements; therapeutics for a spectrum of acute and chronic diseases.
  • End Users: Diagnostic labs, hospitals, clinics, research institutes.
  • Geographies: Americas (with deep dives into the United States, Canada, Brazil, Argentina, Mexico), Europe, Middle East & Africa (including the UK, Germany, France, Saudi Arabia, South Africa), and Asia-Pacific (covering China, India, Japan, Australia, and Southeast Asia).
  • Leading Companies: Market analysis features BiomX Ltd., Invivo Healthcare, Rebiotix Inc., Illumina, BiomeSense, Viome Life Sciences, Azitra, Merck KGaA, Theriva Biologics, and DuPont de Nemours.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Rapid translation of microbiome science is transforming diagnostics and therapeutics, with industry leaders forging partnerships across academia and biotech.
  • Single-cell sequencing, metatranscriptomics, and AI-led analytics are driving next-generation product development and enabling precision interventions.
  • Evolving regulatory guidelines for live biotherapeutic products and companion diagnostics are streamlining approval timelines and reinforcing quality standards.
  • Market participants are expanding domestic manufacturing and optimizing supply chains to increase resilience in response to shifting trade policies and tariffs.
  • Regional leadership is seen in North American and Asia-Pacific centers of excellence, while collaborative consortia in Europe, the Middle East, and Africa are advancing population-specific research and health solutions.
  • Competitive differentiation is increasingly shaped by sustainable sourcing, ethical supply chain management, and robust scientific validation of products.

Tariff Impact: Navigating Trade Policy in Microbiome Supply Chains

Recent U.S. tariff adjustments on imported reagents, bioinformatics hardware, and specialized instruments are increasing operational costs and complicating procurement. Supply chain leaders are implementing nearshoring, multi-source procurement, and inventory strategies to mitigate risks. Investments in domestic lab capabilities support regulatory compliance, while trade associations are negotiating for exemptions and better material classifications to ensure continued clinical progress.

Methodology & Data Sources

This report is informed by in-depth interviews with industry experts, R&D heads, and regulatory specialists, alongside secondary research from peer-reviewed journals, patents, and regulatory records. Analytical frameworks include cross-source data triangulation and qualitative assessments validated by an expert panel. Robust data privacy and research ethics protocols were upheld throughout analysis.

Why This Report Matters

  • Equips senior decision-makers with actionable intelligence to guide investments, operational planning, and portfolio expansion within the human microbiome market.
  • Clarifies competitive and regulatory shifts, enabling informed risk management and tactical responses to evolving sector dynamics.
  • Delivers outcomes-focused recommendations to streamline partnerships, optimize supply chains, and align with emerging therapeutic and technological trends.

Conclusion

The human microbiome market is poised for accelerated innovation as senior leaders integrate new technologies, regulatory guidance, and strategic partnerships. Organizations ready to align operational excellence with scientific advances will capture substantial value as the ecosystem matures.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in development of targeted live biotherapeutic products for specific diseases
5.2. Increasing adoption of precision nutrition solutions based on individual gut microbiome profiling
5.3. Growth in collaborations between pharma and microbiome startups for novel drug discovery platforms
5.4. Expansion of pediatric microbiome research focusing on early-life health and developmental outcomes
5.5. Emergence of synthetic microbial consortia engineered for enhanced gut barrier function and immunity
5.6. Utilization of AI-driven metabolomic analysis to identify microbiome-based diagnostic biomarkers
5.7. Regulatory agencies issuing new guidelines for live biotherapeutic product approval and quality standards
5.8. Integration of fecal microbiota transplantation with standardized protocols for gastrointestinal disorders
5.9. Advances in oral microbiome modulation via next-generation probiotics targeting periodontal diseases
5.10. Development of personalized skincare formulations leveraging skin microbiome sequencing and analytics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Human Microbiome Market, by Product Type
8.1. Introduction
8.2. Fecal Microbiota Transplant
8.2.1. Capsule
8.2.2. Colonoscopy
8.3. Microbiome Sequencing Services
8.3.1. 16S Rrna Sequencing
8.3.2. Metatranscriptomics
8.3.3. Shotgun Metagenomics
8.4. Postbiotics
8.5. Prebiotics
8.5.1. Fructooligosaccharides
8.5.2. Galactooligosaccharides
8.5.3. Inulin
8.6. Probiotics
8.6.1. Bifidobacterium
8.6.2. Lactobacillus
8.7. Synbiotics
9. Human Microbiome Market, by Indication
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Infections
9.4. Metabolic Disorders
9.5. Oral Health
9.6. Respiratory Disorders
9.7. Skin Disorders
10. Human Microbiome Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. Biomarker Discovery
10.2.2. Clinical Diagnostics
10.2.3. Companion Diagnostics
10.3. Supplements
10.4. Therapeutics
10.4.1. Gastrointestinal Disorders
10.4.2. Infections
10.4.3. Metabolic Disorders
10.4.4. Skin Disorders
11. Human Microbiome Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals And Clinics
11.4. Research Institutes
12. Americas Human Microbiome Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Human Microbiome Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Human Microbiome Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. BiomX Ltd.
15.3.2. Invivo Healthcare
15.3.3. Rebiotix Inc.
15.3.4. Illumina, Inc.
15.3.5. BiomeSense, Inc.
15.3.6. Viome Life Sciences, Inc.
15.3.7. Azitra
15.3.8. Merck KGaA
15.3.9. Theriva Biologics, Inc.
15.3.10. DuPont de Nemours, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. HUMAN MICROBIOME MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. HUMAN MICROBIOME MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. HUMAN MICROBIOME MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. HUMAN MICROBIOME MARKET: RESEARCHAI
FIGURE 24. HUMAN MICROBIOME MARKET: RESEARCHSTATISTICS
FIGURE 25. HUMAN MICROBIOME MARKET: RESEARCHCONTACTS
FIGURE 26. HUMAN MICROBIOME MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HUMAN MICROBIOME MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COLONOSCOPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COLONOSCOPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METATRANSCRIPTOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METATRANSCRIPTOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SHOTGUN METAGENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY POSTBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY POSTBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FRUCTOOLIGOSACCHARIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GALACTOOLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GALACTOOLIGOSACCHARIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INULIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INULIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SYNBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SYNBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ORAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ORAL HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 143. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. CANADA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. CANADA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 146. CANADA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 147. CANADA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 148. CANADA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 149. CANADA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 150. CANADA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 151. CANADA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 152. CANADA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 153. CANADA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 158. CANADA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 159. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 160. CANADA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 161. CANADA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. MEXICO HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 166. MEXICO HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 167. MEXICO HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 168. MEXICO HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 169. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 170. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 171. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 172. MEXICO HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 173. MEXICO HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 180. MEXICO HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. MEXICO HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 261. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 262. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 263. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. GERMANY HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 268. GERMANY HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 269. GERMANY HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 270. GERMANY HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 271. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 272. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 273. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 274. GERMANY HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 275. GERMANY HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. GERMANY HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. GERMANY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 281. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 282. GERMANY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 283. GERMANY HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. GERMANY HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. FRANCE HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 288. FRANCE HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 289. FRANCE HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 290. FRANCE HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 291. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 292. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 293. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 294. FRANCE HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 295. FRANCE HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. FRANCE HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. FRANCE HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 300. FRANCE HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 301. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 302. FRANCE HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 303. FRANCE HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. FRANCE HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 321. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 322. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 323. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. RUSSIA HUMAN MICROBIOME MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 326. ITALY HUMAN MICROBIOME MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 327. ITALY HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2018-2024 (USD MILLION)
TABLE 328. ITALY HUMAN MICROBIOME MARKET SIZE, BY FECAL MICROBIOTA TRANSPLANT, 2025-2030 (USD MILLION)
TABLE 329. ITALY HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2018-2024 (USD MILLION)
TABLE 330. ITALY HUMAN MICROBIOME MARKET SIZE, BY MICROBIOME SEQUENCING SERVICES, 2025-2030 (USD MILLION)
TABLE 331. ITALY HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
TABLE 332. ITALY HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, 2025-2030 (USD MILLION)
TABLE 333. ITALY HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
TABLE 334. ITALY HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, 2025-2030 (USD MILLION)
TABLE 335. ITALY HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. ITALY HUMAN MICROBIOME MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 338. ITALY HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 339. ITALY HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 340. ITALY HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 341. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 342. ITALY HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 343. ITALY HUMAN MICROBIOME MARKE

Samples

Loading
LOADING...

Companies Mentioned

  • BiomX Ltd.
  • Invivo Healthcare
  • Rebiotix Inc.
  • Illumina, Inc.
  • BiomeSense, Inc.
  • Viome Life Sciences, Inc.
  • Azitra
  • Merck KGaA
  • Theriva Biologics, Inc.
  • DuPont de Nemours, Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.13 Billion
Compound Annual Growth Rate24.0%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031 - Product Image

Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics, Synbiotics, Diagnostics), Disease (Infectious, Gastrointestinal), Route (Oral, Rectal), CDMO (Formulation, Strain Engineering), Type (BCT/FMT, Live Bacteria) - Global Forecast to 2031

  • Report
  • 371 Pages
  • Global
From
Microbiome Therapeutics Market - Global Forecast 2025-2030 - Product Image

Microbiome Therapeutics Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Human Microbiome - Global Strategic Business Report - Product Image

Human Microbiome - Global Strategic Business Report

  • Report
  • 183 Pages
  • Global
From
Human Microbiome Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 - Product Image

Human Microbiome Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

  • Report
  • 130 Pages
  • Global
From
Microbiome Diagnostics - Global Strategic Business Report - Product Image

Microbiome Diagnostics - Global Strategic Business Report

  • Report
  • 569 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.